Slashdot Mirror

← Back to Stories (view on slashdot.org)

First Anti-Cancer Nanoparticle Trial On Humans a Success

Posted by samzenpus on from the smallest-medicine dept.

An anonymous reader writes "Nanoparticles have been able to disable cancerous cells in living human bodies for the first time. The results are perfect so far, killing tumors with no side effects whatsoever. Mark Davis, project leader at CalTech, says that 'it sneaks in, evades the immune system, delivers the siRNA, and the disassembled components exit out.' Truly amazing."

3 of 260 comments (clear)

  1. Re:Targetting by alexborges · · Score: 4, Insightful

    They have RNA that attaches to cancerous and only cancerous cells. Of course, there are types of cancer that wont "bind" with this thingies, but supposedly, if I remeber correctly, they are the rarest.

    --
    NO SIG
  2. Re:Too small a sample size by Barny · · Score: 5, Insightful

    Not to mention there are now at least 15 extremely happy people out there :)

    --
    ...
    /me sighs
  3. Re:Too small a sample size by chowdahhead · · Score: 5, Insightful

    It's a phase-I trial, it only confirms safety already established in animal models and kinetics. Phase-II and phase-III trials, much larger in scale, assess efficacy and optimum dosing. That will tell us if this can be more effective than traditional chemotherapy (possible) and monoclonal chemotherapy (much more difficult to predict).